-
UPDATE: Goldman Sachs Raises PT on Agilent Technologies Following F3Q Revenue/EPS Report
Thursday, August 15, 2013 - 11:13am | 134In a report published Thursday, Goldman Sachs analyst Isaac Ro reiterated a Neutral rating on Agilent Technologies (NYSE: A), and raised the price target from $46.00 to $48.00. In the report, Agilent Technologies noted, “Agilent reported F3Q revenue/EPS of $1.65bn/$0.68, which beat consensus of...
-
UPDATE: Goldman Sachs Raises PT on Illumina on BaseSpace Thoughts
Thursday, June 27, 2013 - 9:44am | 137In a report published Thursday, Goldman Sachs analyst Isaac Ro reiterated a Neutral rating on Illumina (NASDAQ: ILMN), and raised the price target from $59.00 to $64.00. In the report, Goldman Sachs noted, “We believe BaseSpace is still in its infancy and unlikely to be a material driver of...
-
Life Technologies Corp. (LIFE) Maintains Outperform Rating
Tuesday, March 16, 2010 - 9:11am | 131Analysts Isaac Ro and Jeff Ares at Leerink Swann have released an update on Life Technologies Corp. (NASDAQ: LIFE). The company will soon launch new Attune platform for flow cytometry. Analysts believe that the launch highlights the company’s underappreciated pipeline of new products. Management...
-
Leerink Swann Suspends Millipore (MIL) Rating After Acquisition Announced
Monday, March 1, 2010 - 9:18am | 121Leerink Swann analysts Isaac Ro and Jeff Ares suspended their rating of Millipore Corporation (NYSE: MIL) due to the pending acquisition of the company by Germany's Merck KGaA. The analysts said that they would, "no longer put forth a valuation on MIL shares as our rating is suspended due to the...